Sonnet BioTherapeutics Holdings, Inc. financial data

Symbol
SONN on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Overlook Center, Suite 102, Princeton, NJ
State of incorporation
DE
Fiscal year end
September 30
Former names
Chanticleer Holdings, Inc. (to 3/31/2020), TULVINE SYSTEMS INC (to 3/31/2005)
Latest financial report
10-Q - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 157 % +10%
Debt-to-equity 135 % -34.7%
Return On Assets -174 % -2.71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.01M shares -2.02%
Common Stock, Shares, Outstanding 3.01M shares -2.02%
Entity Public Float 46.2M USD +532%
Common Stock, Value, Issued 300 USD -2.28%
Weighted Average Number of Shares Outstanding, Basic 2.02M shares +326%
Weighted Average Number of Shares Outstanding, Diluted 2.02M shares +326%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1M USD +5269%
Research and Development Expense 6.98M USD -19.9%
General and Administrative Expense 7.44M USD +26.6%
Operating Income (Loss) -13.4M USD +7.19%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3M USD -157%
Income Tax Expense (Benefit) 158K USD
Net Income (Loss) Attributable to Parent -9.43M USD +34.8%
Earnings Per Share, Basic -10.5 USD/shares +92%
Earnings Per Share, Diluted -10.5 USD/shares +92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 149K USD -93.4%
Assets, Current 6.73M USD +45.4%
Property, Plant and Equipment, Net 17.3K USD -42.6%
Operating Lease, Right-of-Use Asset 104K USD -41%
Other Assets, Noncurrent 213K USD -56.7%
Assets 7.18M USD +34.6%
Accounts Payable, Current 1.64M USD -0.93%
Accrued Liabilities, Current 3.32M USD +3.47%
Liabilities, Current 3.12M USD +17.6%
Operating Lease, Liability, Noncurrent 23.6K USD -78.7%
Liabilities 3.15M USD +13.7%
Retained Earnings (Accumulated Deficit) -121M USD -8.46%
Stockholders' Equity Attributable to Parent 4.04M USD +56.9%
Liabilities and Equity 7.18M USD +34.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.91M USD +5.87%
Net Cash Provided by (Used in) Financing Activities 7.62M USD +98.6%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 3.01M shares -2.02%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.71M USD +531%
Deferred Tax Assets, Valuation Allowance 36.5M USD -1.67%
Deferred Tax Assets, Gross 36.5M USD -1.73%
Operating Lease, Liability 131K USD -35.8%
Depreciation 3.21K USD 0%
Lessee, Operating Lease, Liability, to be Paid 144K USD -39.4%
Operating Lease, Liability, Current 87.3K USD +15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48.2K USD -49.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 95.5K USD +2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.8K USD -61.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 48.2K USD -49.5%
Deferred Tax Assets, Operating Loss Carryforwards 26.8M USD -4.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Additional Paid in Capital 125M USD +9.56%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 39.5K USD -36.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares